Nonalcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Nonalcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
This clinical trial from West Virginia University assesses the effectiveness of endoscopic sleeve gastroplasty for nonalcoholic fatty liver …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Weight, Energy, Lipids, and the Liver (WELL) Study [NA]
The WELL study is an ongoing clinical trial investigating weight, energy, lipid levels, and liver health in people with Nonalcoholic Fatty L…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Digital Therapy for Fatty Liver Disease [NA]
This clinical trial update indicates an active but not recruiting study of a digital therapy for nonalcoholic fatty liver disease and nonalc…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)
This clinical trial entry describes a study comparing S-Viscosity and Canon Dispersion Slope in metabolic dysfunction-associated steatotic l…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
A recruiting clinical study uses single-cell multiomics and spatiotemporal omics to investigate mechanisms of liver degeneration. Sponsored …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Androgens and NAFLD Longitudinal Cohort Study
A longitudinal cohort study sponsored by University of California, San Francisco investigating the relationship between androgens and NAFLD/…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Human Models of Selective Insulin Resistance: Alpelisib, Part I [Phase 1]
Clinical trial update for a Phase 1 study evaluating alpelisib in models of selective insulin resistance, investigating its effects in insul…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Effect of Insulin Lowering on Lipogenesis [Phase 1]
A Phase 1 clinical trial update evaluating whether lowering insulin affects lipogenesis in conditions such as hyperinsulinemia, insulin resi…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Accurate Point of Care Liver Disease Diagnostics (Phase 2)
Phase 2 clinical trial evaluating accurate point-of-careDiagnostics for liver disease, currently recruiting. Sponsored by the University of …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: RE and Probiotics in MAFLD/NAFLD [NA]
Clinical trial update from Nicolaus Copernicus University evaluating RE and probiotics for metabolic dysfunction-associated fatty liver dise…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
A longitudinal observational study across the full spectrum of nonalcoholic fatty liver disease, including nonalcoholic steatohepatitis, is …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver Disease
Clinical trial update evaluating short- and long-term clinical and patient-reported outcomes of intragastric balloon placement in Nonalcohol…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Phase 2b Study of GSK4532990 in Adults With NASH [Phase 2]
Phase 2b trial update for GSK4532990 in adults with nonalcoholic fatty liver disease, specifically nonalcoholic steatohepatitis (NASH). The …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss [NA]
Clinical trial NCT07237750 comparing Endoscopic Radial Compression Gastroplasty (iWAIST) to optimized lifestyle intervention for weight loss…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Fully Automated High-Throughput Quantitative MRI of the Liver
This update describes a trial of a fully automated high-throughput quantitative MRI method for liver imaging, with recruitment ongoing in he…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease [NA]
A clinical trial is evaluating a GLP-1 receptor agonist for effects on alcohol consumption, metabolism, and liver parameters in patients wit…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease
This document provides a clinical trial update focusing on patient and physician perspectives regarding nonalcoholic fatty liver disease.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Evaluation of Miricorilant on Liver Fat in Patients With MASLD [Phase 1]
Phase 1 clinical trial evaluating Miricorilant on liver fat in patients with MASLD, including NASH and related conditions; currently recruit…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disease [NA]
This clinical trial update describes a study evaluating personalized transcranial magnetic stimulation for metabolic dysfunction in alcoholi…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Effect of a GnRH Analog on Hepatic Steatosis [Phase 4]
A Phase 4 clinical trial is recruiting to assess the effect of a gonadotropin-releasing hormone (GnRH) analog on hepatic steatosis in metabo…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET [NA]
A clinical trial update describes measuring amino acid and glucose metabolism in healthy volunteers and patients with nonalcoholic fatty liv…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients [Phase 4]
Phase 4 clinical trial update on empagliflozin for liver fibrosis and cirrhosis in chronic hepatitis B with NAFLD; currently active but not …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: RTX001 Autologous Engineered Macrophages for Liver Cirrhosis [Phase 1, Phase 2]
RTX001 is an autologous engineered macrophage therapy being investigated in Phase 1/2 trials for end-stage liver disease and liver cirrhosis…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial [Phase 2]
Phase 2 mechanistic clinical trial evaluating a probiotic mixture for metabolic dysfunction-associated steatotic liver disease (MASLD) and n…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Nonalcoholic Fatty Liver Disease in HIV Database
This entry describes a clinical trial registry study on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in people living w…